Chlamydia pneumoniae is not detectable in subretinal neovascular membranes in the exudative stage of age-related macular degeneration

Acta Ophthalmologica Scandinavica

Volumn 84, Issue 3, 2006, Pages 333-337

  Kessler, Werner ^a,d   Jantos, Christian A ^b   Dreier, Jens ^c   Pavlovic, Sima ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b EVANGELISCHES KRANKENHAUS   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d Department of Opthalmology ^*  (Germany)

Author keywords

Age related macular degeneration; Chlamydia pneumoniae; Polymerase chain reaction; Subretinal membrane

Indexed keywords

BACTERIAL DNA;

AGED; ARTICLE; ATHEROSCLEROSIS; BACTERIUM DETECTION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXUDATE; EYE SURGERY; HUMAN; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SUBRETINAL NEOVASCULARIZATION;

AGED; AGED, 80 AND OVER; CHLAMYDOPHILA PNEUMONIAE; DNA, BACTERIAL; EXUDATES AND TRANSUDATES; HUMANS; MACULAR DEGENERATION; OPHTHALMOLOGIC SURGICAL PROCEDURES; POLYMERASE CHAIN REACTION; RETINAL NEOVASCULARIZATION;

EID: 33646776761     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2005.00591.x     Document Type: Article

References (54)

1. Anderson JL, Muhlestein JB, Carlquist J et al. (1999): Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) Study. Circulation 99: 1540-1547.
2. Bodetti TJ & Timms P (2000): Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of humans and koalas. Infect Immun 68: 2744-2747.
3. Campbell LA, O'Brien ER, Cappuccio AL et al. (1995): Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 172: 585-588.
4. Chaine G, Hullo A, Sahel J et al. (1998): Case-control study of the risk factors for age-related macular degeneration. France-DMLA Study Group. Br J Ophthalmol 82: 996-1002.
5. Chen EY, Liao YC, Smith DH, Barrera-Saldana HA, Gelinas RE & Seeburg PH (1989): The human growtN hormone locus: nucleotide sequence, biology and evolution. Genomics 4: 479-497.
6. Curcio CA, Millican CL, Bailey T & Kruth HS (2001): Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci 42: 265-274.
7. Dansky HM, Charlton SA, Harper MM & Smith JD (1997): T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A 94: 4642-4646.
8. Daugherty A, Pure E, Delfel-Butteiger D, Chen S, Leferovich J, Roselaar SE & Rader DJ (1997): The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. J Clin Invest 100: 1575-1580.
9. Dimitrova G, Tamaki Y & Kato S (2002): Retrobulbar circulation in patients with age-related maculopathy. Eye 16: 580-586.
10. Einarsson S, Sigurdsson HK, Magnusdottir SD, Erlendsdottir H, Briem H & Gudmundsson S (1994): Age-specific prevalence of antibodies against Chlamydia pneumoniae in Iceland. Scand J Infect Dis 26: 393-397.
11. Emre U, Roblin PM, Gelling M, Dumornay W, Rao M, Hammerschlag MR & Schachter J (1994): The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 148: 727-732.
12. Espinola-Klein C, Rupprecht HJ, Blankenberg S et al. (2002): Impact of infectious burden on progression of carotid atherosclerosis. Stroke 33: 2581-2586.
13. Gaydos CA, Roblin PM, Hammerschlag MR, Hyman CL, Eiden JJ, Schachter J & Quinn TC (1994): Diagnostic utility of PCR-enzyme immunoassay, culture and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 32: 903-905.
14. Gibbs RG, Sian M, Mitchell AW, Greenhalgh RM, Davies AH & Carey N (2000): Chlamydia pneumoniae does not influence atherosclerotic plaque behaviour in patients with established carotid artery stenosis. Stroke 31: 2930-2935.
15. Green WR & Enger C (1993): Age-related macular degeneration histopathologic studies. The 1992 Lorenz E Zimmerman Lecture. Ophthalmology 100: 1519-1535.
16. Hageman GS, Anderson DH, Johnson LV et al. (2005): A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102: 7227-7232.
17. Ikeda T, Obayashi H, Hasegawa G, Nakamura N, Yoshikawa T, Imamura Y, Koizumi K & Kinoshita S (2001): Paraoxonase gene polymorphisms and plasma oxidized low-density lipoprotein level as possible risk factors for exudative age-related macular degeneration. Am J Ophthalmol 132: 191-195.
18. Ishida O, Oku H, Ikeda T, Nishimura M, Kawagoe K & Nakamura K (2003): Is Chlamydia pneumoniae infection a risk factor for age-related macular degeneration? Br J Ophthalmol 87: 523-524.
19. Kalayoglu MV, Bula D, Arroyo J, Gragoudas ES & Miller JW (2003b): Detection of Chlamydia pneumoniae in choroidal neovascular membranes isolated from patients with age-related macular degeneration. ARVO Abstract 5023/B682.
20. Kalayoglu MV & Byrne GI (1998): Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis 177: 725-729.
21. Kalayoglu MV, Galvan C, Mahdi OS, Byrne GI & Mansour S (2003a): Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch Ophthalmol 121: 478-482.
22. Kaukoranta-Tolvanen SS, Laitinen K, Saikku P & Leinonen M (1994): Chlamydia pneumoniae multiplies in human endothelial cells in vitro. Microb Pathog 16: 313-319.
23. Kijlstra A, La Heij E & Hendrikse F (2005): Immunological factors in the pathogenesis and treatment of age-related macular degeneration. Ocul Immunol Inflamm 13: 3-11.
24. Klein R, Klein BE & Franke T (1993a): The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 100: 406-414.
25. Klein R, Klein BE & Jensen SC (1997): The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 104: 1804-1812.
26. Klein R, Klein BE, Linton KL & DeMets DL (1993b): The Beaver Dam Eye Study: The relation of age-related maculopathy to smoking. Am J Epidemiol 137: 190-200.
27. Klein R, Klein BE & Moss SE (1998): Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. Am J Epidemiol 147: 103-110.
28. Klein R, Klein BE, Tomany SC & Cruickshanks KJ (2003): The association of cardiovascular disease with the longterm incidence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 110: 1273-1280.
29. Klein R, Klein BE, Tomany SC, Meuer SM & Huang GH (2002): Ten-year incidence and progression of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 109: 1767-1779.
30. Klein RJ, Zeiss C & Chew EY et al. (2005): Complement factor H polymorphism in age-related macular degeneration. Science 308: 385-389.
31. Kol A, Sukhova GK, Lichtman AH & Libby P (1998): Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumour necrosis factor-alpha and matrix metalloproteinase expression. Circulation 98: 300-307.
32. Kuo CC, Jackson LA, Campbell LA & Grayston JT (1995): Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8: 451-461.
33. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL & Grayston JT (1993): Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167: 841-849.
34. LaBiche R, Koziol D, Quinn TC, Gaydos C, Azhar S, Ketron G, Sood S & DeGraba TJ (2001): Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke 32: 855-860.
35. Ley BE, Linton CJ, Bennett DM, Jalal H, Foot AB & Millar MR (1998): Detection of bacteraemia in patients with fever and neutropenia using 16S rRNA gene amplification by polymerase chain reaction. Eur J Clin Microbiol Infect Dis 17: 247-253.
36. Mayr M, Metzler B, Kiechl S, Willeit J, Schett G, Xu Q & Wick G (1999): Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: Immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 99: 1560-1566.
37. Merrill PT, LoRusso FJ, Lomeo MD, Saxe SJ, Khan MM & Lambert HM (1999): Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration. Ophthalmology 106: 782-789.
38. Miller DM, Espinosa-Heidmann DG, Legra J, Dubovy SR, Suner IJ, Sedmak DD, Dix RD & Cousins SW (2004): The association of prior cytomegalovirus infection with neovascular age-related macular degeneration. Am J Ophthalmol 138: 323-328.
39. Miyashita N, Niki Y, Nakajima M, Fukano H & Matsushima T (2001): Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults. Chest 119: 1416-1419.
40. Ong G, Thomas BJ, Mansfield AO, Davidson BR & Taylor-Robinson D (1996): Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 49: 102-106.
41. Ramirez JA (1996): Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann Intern Med 125: 979-982.
42. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttunen JK & Valtonen V (1988): Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2: 983-986.
43. van der Schaft TL, Mooy CM, de Bruijn WC & de Jong PT (1993): Early stages of age-related macular degeneration: An immunofluorescence and electron microscopy study. Br J Ophthalmol 77: 657-661.
44. Sessa R, Di Pietro M, Schiavoni G, Santino I, Cipriani P, Romano S, Penco M & del Piano M (2001): Prevalence of Chlamydia pneumoniae in peripheral blood mononuclear cells in Italian patients with acute ischaemic heart disease. Atherosclerosis 159: 521-525.
45. Smieja M, Cronin L, Levine M, Goldsmith CH, Yusuf S & Mahony JB (2001): Previous exposure to Chlamydia pneumoniae, Helicobacter pylori and other infections in Canadian patients with ischaemic heart disease. Can J Cardiol 17: 270-276.
46. Steinhoff D, Lode H & Ruckdeschel G et al. (1996): Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin. Clin Infect Dis 22: 958-964.
47. Tong CY & Sillis M (1993): Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR. J Clin Pathol 46: 313-317.
48. Torzewski J, Oldroyd R, Lachmann P, Fitzsimmons C, Proudfoot D & Bowyer D (1996): Complement-induced release of monocyte chemotactic protein-1 from human smooth muscle cells. A possible initiating event in atherosclerotic lesion formation. Arterioscler Thromb Vasc Biol 16: 673-677.
49. Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE & de Jong PT (1995): Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 142: 404-409.
50. Vingerling JR, Hofman A, Grobbee DE & de Jong PT (1996): Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol 114: 1193-1196.
51. Virok D, Loboda A & Kari L et al. (2003): Infection of U937 monocytic cells with Chlamydia pneumoniae induces extensive changes in host cell gene expression. J Infect Dis 188: 1310-1321.
52. Weiss SM, Roblin PM & Gaydos CA et al. (1996): Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 173: 957-962.
53. Wiesli P, Czerwenka W, Meniconi A, Maly FE, Hoffmann U, Vetter W & Schulthess G (2002): Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: A randomized, double-blind, placebo-controlled trial. Circulation 105: 2646-2652.
54. Yamaguchi H, Haranaga S, Widen R, Friedman H & Yamamoto Y (2002): Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages. Infect Immun 70: 2392-2398.